Kampo medicines, Rokumigan, Hachimijiogan, and Goshajinkigan, significantly inhibit glucagon-induced CREB activation
Megumi Funakoshi-Tago, Seisho Yu, Akira Kushida, Kazusane Takeuchi, Hiroomi Tamura
研究成果: Article › 査読
2
被引用数
(Scopus)